{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:01:28Z","timestamp":1779256888088,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A1B03032935"],"award-info":[{"award-number":["2017R1D1A1B03032935"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2025964"],"award-info":[{"award-number":["2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3C7A1029609"],"award-info":[{"award-number":["2017M3C7A1029609"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C1014372"],"award-info":[{"award-number":["2020R1A2C1014372"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1I1A1A01063296"],"award-info":[{"award-number":["2022R1I1A1A01063296"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inborn errors of metabolism (IEMs) are common causes of neurodevelopmental disorders, including microcephaly, hyperactivity, and intellectual disability. However, the synaptic mechanisms of and pharmacological interventions for the neurological complications of most IEMs are unclear. Here, we report that metabolic dysfunction perturbs neuronal NMDA receptor (NMDAR) homeostasis and that the restoration of NMDAR signaling ameliorates neurodevelopmental and cognitive deficits in IEM model mice that lack aminopeptidase P1. Aminopeptidase P1-deficient (Xpnpep1<jats:sup>\u2013\/\u2013<\/jats:sup>) mice, with a disruption of the proline-specific metalloprotease gene <jats:italic>Xpnpep1<\/jats:italic>, exhibit hippocampal neurodegeneration, behavioral hyperactivity, and impaired hippocampus-dependent learning. In this study, we found that GluN1 and GluN2A expression, NMDAR activity, and the NMDAR-dependent long-term potentiation (LTP) of excitatory synaptic transmission were markedly enhanced in the hippocampi of Xpnpep1<jats:sup>\u2013\/\u2013<\/jats:sup> mice. The exaggerated NMDAR activity and NMDAR-dependent LTP were reversed by the NMDAR antagonist memantine. A single administration of memantine reversed hyperactivity in adult Xpnpep1<jats:sup>\u2013\/\u2013<\/jats:sup> mice without improving learning and memory. Furthermore, chronic administration of memantine ameliorated hippocampal neurodegeneration, hyperactivity, and impaired learning and memory in Xpnpep1<jats:sup>\u2013\/\u2013<\/jats:sup> mice. In addition, abnormally enhanced NMDAR-dependent LTP and NMDAR downstream signaling in the hippocampi of Xpnpep1<jats:sup>\u2013\/\u2013<\/jats:sup> mice were reversed by chronic memantine treatment. These results suggest that the metabolic dysfunction caused by aminopeptidase P1 deficiency leads to synaptic dysfunction with excessive NMDAR activity, and the restoration of synaptic function may be a potential therapeutic strategy for the treatment of neurological complications related to IEMs.<\/jats:p>","DOI":"10.1038\/s12276-022-00818-9","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:03:44Z","timestamp":1659524624000},"page":"1109-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Suppression of exaggerated NMDAR activity by memantine treatment ameliorates neurological and behavioral deficits in aminopeptidase P1-deficient mice"],"prefix":"10.1038","volume":"54","author":[{"given":"Young-Soo","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-1593","authenticated-orcid":false,"given":"Sang Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Pyo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Seok","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoung-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrg1880","volume":"7","author":"B Lanpher","year":"2006","unstructured":"Lanpher, B., Brunetti-Pierri, N. & Lee, B. Inborn errors of metabolism: the flux from Mendelian to complex diseases. Nat. Rev. Genet. 7, 449\u2013460 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","volume":"105","author":"DA Applegarth","year":"2000","unstructured":"Applegarth, D. A., Toone, J. R. & Lowry, R. B. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 105, e10 (2000).","journal-title":"Pediatrics"},{"key":"818_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/adc.2005.091637","volume":"91","author":"S Sanderson","year":"2006","unstructured":"Sanderson, S., Green, A., Preece, M. A. & Burton, H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch. Dis. Child. 91, 896\u2013899 (2006).","journal-title":"Arch. Dis. Child."},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-90-481-9485-8_23","volume":"686","author":"T Pampols","year":"2010","unstructured":"Pampols, T. Inherited metabolic rare disease. Adv. Exp. Med. Biol. 686, 397\u2013431 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41436-018-0022-8","volume":"21","author":"CR Ferreira","year":"2019","unstructured":"Ferreira, C. R., van Karnebeek, C. D. M., Vockley, J. & Blau, N. A proposed nosology of inborn errors of metabolism. Genet. Med. 21, 102\u2013106 (2019).","journal-title":"Genet. Med."},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ajmg.c.10018","volume":"117C","author":"SG Kahler","year":"2003","unstructured":"Kahler, S. G. & Fahey, M. C. Metabolic disorders and mental retardation. Am. J. Med. Genet. C. Semin. Med. Genet. 117C, 31\u201341 (2003).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ymgme.2011.11.191","volume":"105","author":"CD van Karnebeek","year":"2012","unstructured":"van Karnebeek, C. D. & Stockler, S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol. Genet. Metab. 105, 368\u2013381 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"818_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/archdischild-2012-302840","volume":"98","author":"G Pierre","year":"2013","unstructured":"Pierre, G. Neurodegenerative disorders and metabolic disease. Arch. Dis. Child. 98, 618\u2013624 (2013).","journal-title":"Arch. Dis. Child."},{"key":"818_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10545-007-0661-4","volume":"30","author":"F Sedel","year":"2007","unstructured":"Sedel, F. et al. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J. Inherit. Metab. Dis. 30, 631\u2013641 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2013.05.013","volume":"49","author":"M Ghaziuddin","year":"2013","unstructured":"Ghaziuddin, M. & Al-Owain, M. Autism spectrum disorders and inborn errors of metabolism: an update. Pediatr. Neurol. 49, 232\u2013236 (2013).","journal-title":"Pediatr. Neurol."},{"key":"818_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.31887\/DCNS.2018.20.4\/jmsaudubray","volume":"20","author":"JM Saudubray","year":"2018","unstructured":"Saudubray, J. M. & Garcia-Cazorla, A. An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders. Dialogues Clin. Neurosci. 20, 301\u2013325 (2018).","journal-title":"Dialogues Clin. Neurosci."},{"key":"818_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/BF02072514","volume":"152","author":"S Schweitzer","year":"1993","unstructured":"Schweitzer, S., Shin, Y., Jakobs, C. & Brodehl, J. Long-term outcome in 134 patients with galactosaemia. Eur. J. Pediatr. 152, 36\u201343 (1993).","journal-title":"Eur. J. Pediatr."},{"key":"818_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/adc.65.5.472","volume":"65","author":"I Smith","year":"1990","unstructured":"Smith, I., Beasley, M. G. & Ades, A. E. Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child. 65, 472\u2013478 (1990).","journal-title":"Arch. Dis. Child."},{"key":"818_CR14","first-page":"1","volume":"37","author":"SH Mudd","year":"1985","unstructured":"Mudd, S. H. et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Hum. Genet. 37, 1\u201331 (1985).","journal-title":"Am. J. Hum. Genet."},{"key":"818_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/mgme.2000.3050","volume":"71","author":"JD McDonald","year":"2000","unstructured":"McDonald, J. D. Production of mouse models for the study of human inborn errors of metabolism. Mol. Genet. Metab. 71, 240\u2013244 (2000).","journal-title":"Mol. Genet. Metab."},{"key":"818_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-981-15-2389-2_9","volume":"1236","author":"CA Moro","year":"2020","unstructured":"Moro, C. A. & Hanna-Rose, W. Animal model contributions to congenital metabolic disease. Adv. Exp. Med. Biol. 1236, 225\u2013244 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"818_CR17","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1021\/bi001585c","volume":"39","author":"GS Cottrell","year":"2000","unstructured":"Cottrell, G. S., Hooper, N. M. & Turner, A. J. Cloning, expression, and characterization of human cytosolic aminopeptidase P: a single manganese(II)-dependent enzyme. Biochemistry 39, 15121\u201315128 (2000).","journal-title":"Biochemistry"},{"key":"818_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.abb.2004.12.023","volume":"435","author":"C Ersahin","year":"2005","unstructured":"Ersahin, C., Szpaderska, A. M., Orawski, A. T. & Simmons, W. H. Aminopeptidase P isozyme expression in human tissues and peripheral blood mononuclear cell fractions. Arch. Biochem. Biophys. 435, 303\u2013310 (2005).","journal-title":"Arch. Biochem. Biophys."},{"key":"818_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF01804246","volume":"11","author":"N Blau","year":"1988","unstructured":"Blau, N., Niederwieser, A. & Shmerling, D. H. Peptiduria presumably caused by aminopeptidase-P deficiency. A new inborn error of metabolism. J. Inherit. Metab. Dis. 11, 240\u2013242 (1988).","journal-title":"J. Inherit. Metab. Dis."},{"key":"818_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbrc.2012.10.104","volume":"429","author":"SH Yoon","year":"2012","unstructured":"Yoon, S. H. et al. Developmental retardation, microcephaly, and peptiduria in mice without aminopeptidase P1. Biochem. Biophys. Res. Commun. 429, 204\u2013209 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/gbb.12419","volume":"17","author":"YS Bae","year":"2018","unstructured":"Bae, Y. S. et al. Deficiency of aminopeptidase P1 causes behavioral hyperactivity, cognitive deficits, and hippocampal neurodegeneration. Genes Brain Behav. 17, 126\u2013138 (2018).","journal-title":"Genes Brain Behav."},{"key":"818_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79656-6","volume":"11","author":"SH Yoon","year":"2021","unstructured":"Yoon, S. H. et al. Altered hippocampal gene expression, glial cell population, and neuronal excitability in aminopeptidase P1 deficiency. Sci. Rep. 11, 932 (2021).","journal-title":"Sci. Rep."},{"key":"818_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrd1311","volume":"3","author":"A Witt","year":"2004","unstructured":"Witt, A., Macdonald, N. & Kirkpatrick, P. Memantine hydrochloride. Nat. Rev. Drug Discov. 3, 109\u2013110 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"818_CR24","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1523\/JNEUROSCI.4306-08.2009","volume":"29","author":"MH Kim","year":"2009","unstructured":"Kim, M. H. et al. Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53. J. Neurosci. 29, 1586\u20131595 (2009).","journal-title":"J. Neurosci."},{"key":"818_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","volume":"499","author":"HS Chen","year":"1997","unstructured":"Chen, H. S. & Lipton, S. A. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. 499, 27\u201346 (1997).","journal-title":"J. Physiol."},{"key":"818_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fphar.2013.00024","volume":"4","author":"M Martina","year":"2013","unstructured":"Martina, M., Comas, T. & Mealing, G. A. Selective pharmacological modulation of pyramidal neurons and interneurons in the CA1 region of the rat hippocampus. Front. Pharmacol. 4, 24 (2013).","journal-title":"Front. Pharmacol."},{"key":"818_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/sj.cdd.4401344","volume":"11","author":"SA Lipton","year":"2004","unstructured":"Lipton, S. A. & Chen, H. S. Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine. Cell Death Differ. 11, 18\u201320 (2004).","journal-title":"Cell Death Differ."},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons, C. G., Stoffler, A. & Danysz, W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2212too little activation is bad, too much is even worse. Neuropharmacology 53, 699\u2013723 (2007).","journal-title":"Neuropharmacology"},{"key":"818_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1124\/jpet.105.085142","volume":"314","author":"HS Chen","year":"2005","unstructured":"Chen, H. S. & Lipton, S. A. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. J. Pharmacol. Exp. Ther. 314, 961\u2013971 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"818_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nn992","volume":"6","author":"SG Anagnostaras","year":"2003","unstructured":"Anagnostaras, S. G. et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6, 51\u201358 (2003).","journal-title":"Nat. Neurosci."},{"key":"818_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1101\/lm.7.1.58","volume":"7","author":"SG Anagnostaras","year":"2000","unstructured":"Anagnostaras, S. G., Josselyn, S. A., Frankland, P. W. & Silva, A. J. Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. Learn. Mem. 7, 58\u201372 (2000).","journal-title":"Learn. Mem."},{"key":"818_CR32","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton, S. A. et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA 94, 5923\u20135928 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"818_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.mp.4000976","volume":"7","author":"AV Glushakov","year":"2002","unstructured":"Glushakov, A. V. et al. Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria. Mol. Psychiatry 7, 359\u2013367 (2002).","journal-title":"Mol. Psychiatry"},{"key":"818_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10545-009-0922-5","volume":"32","author":"A Garcia-Cazorla","year":"2009","unstructured":"Garcia-Cazorla, A. et al. Mental retardation and inborn errors of metabolism. J. Inherit. Metab. Dis. 32, 597\u2013608 (2009).","journal-title":"J. Inherit. Metab. Dis."},{"key":"818_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0022-3476(65)80121-4","volume":"66","author":"NA Carson","year":"1965","unstructured":"Carson, N. A., Dent, C. E., Field, C. M. & Gaull, G. E. Homocystinuria: clinical and pathological review of ten cases. J. Pediatr. 66, 565\u2013583 (1965).","journal-title":"J. Pediatr."},{"key":"818_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1192\/bjp.bp.107.045021","volume":"193","author":"GH Murphy","year":"2008","unstructured":"Murphy, G. H. et al. Adults with untreated phenylketonuria: out of sight, out of mind. Br. J. Psychiatry 193, 501\u2013502 (2008).","journal-title":"Br. J. Psychiatry"},{"key":"818_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/brain\/awh354","volume":"128","author":"AV Glushakov","year":"2005","unstructured":"Glushakov, A. V. et al. Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain 128, 300\u2013307 (2005).","journal-title":"Brain"},{"key":"818_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00004647-200103000-00011","volume":"21","author":"A Rupp","year":"2001","unstructured":"Rupp, A. et al. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. J. Cereb. Blood Flow. Metab. 21, 276\u2013284 (2001).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"818_CR39","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1152\/jn.00809.2012","volume":"110","author":"AD Bolton","year":"2013","unstructured":"Bolton, A. D., Phillips, M. A. & Constantine-Paton, M. Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition. J. Neurophysiol. 110, 1567\u20131582 (2013).","journal-title":"J. Neurophysiol."},{"key":"818_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1096\/fasebj.9.9.7601338","volume":"9","author":"G Vanhoof","year":"1995","unstructured":"Vanhoof, G., Goossens, F., De Meester, I., Hendriks, D. & Scharpe, S. Proline motifs in peptides and their biological processing. FASEB J. 9, 736\u2013744 (1995).","journal-title":"FASEB J."},{"key":"818_CR41","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.neuropharm.2005.06.006","volume":"49","author":"JR Moskal","year":"2005","unstructured":"Moskal, J. R. et al. GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator. Neuropharmacology 49, 1077\u20131087 (2005).","journal-title":"Neuropharmacology"},{"key":"818_CR42","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1152\/jn.00290.2014","volume":"112","author":"CE Vaaga","year":"2014","unstructured":"Vaaga, C. E., Tovar, K. R. & Westbrook, G. L. The IGF-derived tripeptide Gly-Pro-Glu is a weak NMDA receptor agonist. J. Neurophysiol. 112, 1241\u20131245 (2014).","journal-title":"J. Neurophysiol."},{"key":"818_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.1993.tb26216.x","volume":"692","author":"VR Sara","year":"1993","unstructured":"Sara, V. R. et al. The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system. Ann. N. Y. Acad. Sci. 692, 183\u2013191 (1993).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"818_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00726-008-0073-2","volume":"35","author":"SM Krane","year":"2008","unstructured":"Krane, S. M. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35, 703\u2013710 (2008).","journal-title":"Amino Acids"},{"key":"818_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hipo.23213","volume":"30","author":"HC Dringenberg","year":"2020","unstructured":"Dringenberg, H. C. The history of long-term potentiation as a memory mechanism: controversies, confirmation, and some lessons to remember. Hippocampus 30, 987\u20131012 (2020).","journal-title":"Hippocampus"},{"key":"818_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2303","volume":"9","author":"G Neves","year":"2008","unstructured":"Neves, G., Cooke, S. F. & Bliss, T. V. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9, 65\u201375 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"818_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/24790","volume":"396","author":"M Migaud","year":"1998","unstructured":"Migaud, M. et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396, 433\u2013439 (1998).","journal-title":"Nature"},{"key":"818_CR48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0896-6273(00)80225-1","volume":"17","author":"Z Jia","year":"1996","unstructured":"Jia, Z. et al. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17, 945\u2013956 (1996).","journal-title":"Neuron"},{"key":"818_CR49","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1093\/emboj\/19.12.2775","volume":"19","author":"N Uetani","year":"2000","unstructured":"Uetani, N. et al. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J. 19, 2775\u20132785 (2000).","journal-title":"EMBO J."},{"key":"818_CR50","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1523\/JNEUROSCI.22-07-02753.2002","volume":"22","author":"Y Gu","year":"2002","unstructured":"Gu, Y. et al. Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J. Neurosci. 22, 2753\u20132763 (2002).","journal-title":"J. Neurosci."},{"key":"818_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1113\/jphysiol.2004.081802","volume":"565","author":"FA Taverna","year":"2005","unstructured":"Taverna, F. A. et al. Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation. J. Physiol. 565, 579\u2013591 (2005).","journal-title":"J. Physiol."},{"key":"818_CR52","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1126\/science.281.5385.2038","volume":"281","author":"EI Moser","year":"1998","unstructured":"Moser, E. I., Krobert, K. A., Moser, M. B. & Morris, R. G. Impaired spatial learning after saturation of long-term potentiation. Science 281, 2038\u20132042 (1998).","journal-title":"Science"},{"key":"818_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1523\/JNEUROSCI.21-01-00356.2001","volume":"21","author":"VH Brun","year":"2001","unstructured":"Brun, V. H., Ytterbo, K., Morris, R. G., Moser, M. B. & Moser, E. I. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation. J. Neurosci. 21, 356\u2013362 (2001).","journal-title":"J. Neurosci."},{"key":"818_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/jn.00394.2001","volume":"87","author":"DA Henze","year":"2002","unstructured":"Henze, D. A., McMahon, D. B., Harris, K. M. & Barrionuevo, G. Giant miniature EPSCs at the hippocampal mossy fiber to CA3 pyramidal cell synapse are monoquantal. J. Neurophysiol. 87, 15\u201329 (2002).","journal-title":"J. Neurophysiol."},{"key":"818_CR55","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrn.2017.10","volume":"18","author":"N Rebola","year":"2017","unstructured":"Rebola, N., Carta, M. & Mulle, C. Operation and plasticity of hippocampal CA3 circuits: implications for memory encoding. Nat. Rev. Neurosci. 18, 208\u2013220 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"818_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","volume":"30","author":"XX Dong","year":"2009","unstructured":"Dong, X. X., Wang, Y. & Qin, Z. H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 30, 379\u2013387 (2009).","journal-title":"Acta Pharmacol. Sin."},{"key":"818_CR57","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.neuron.2013.10.033","volume":"80","author":"JK Makara","year":"2013","unstructured":"Makara, J. K. & Magee, J. C. Variable dendritic integration in hippocampal CA3 pyramidal neurons. Neuron 80, 1438\u20131450 (2013).","journal-title":"Neuron"},{"key":"818_CR58","doi-asserted-by":"publisher","first-page":"RRN1291","DOI":"10.1371\/currents.RRN1291","volume":"3","author":"MG Beconi","year":"2011","unstructured":"Beconi, M. G. et al. Pharmacokinetics of memantine in rats and mice. PLoS Curr. 3, RRN1291 (2011).","journal-title":"PLoS Curr."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-022-00818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-022-00818-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-022-00818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:07:50Z","timestamp":1669230470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-022-00818-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1038\/s12276-022-00818-9","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}